Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 10.15p 10.00p 10.30p 10.15p 10.15p 10.15p 125,987 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -0.5 -0.2 - 21

Eden Research Share Discussion Threads

Showing 6701 to 6725 of 7750 messages
Chat Pages: Latest  274  273  272  271  270  269  268  267  266  265  264  263  Older
DateSubjectAuthorDiscuss
04/4/2019
19:50
Does Eden have to pay anything to Proactive?
northwick
04/4/2019
19:15
Super, The politico article is a good example of why Eden should not allow others, in this case Proactive Investors, to refer to Cedroz as a pesticide. It is to my mind, potentially very damaging to who Eden are and what they produce. Errors like this should be corrected and insisted upon. Eden cannot afford to be misunderstood by the investing community.
investingisatrickygame
04/4/2019
18:49
The biggest Oxymoron= Croplife Croplife Defending Extinction. hTTps://www.croplife.com/crop-inputs/herbicides/the-war-on-glyphosate-spreads/
supersonico
04/4/2019
15:48
Edit. Good point, but this won't amount ot much in four months of early sales. I think this year may be touch and go in terms of their balance sheet, unless they get something substantial out of Sustainea, and this is the sliver of truth behind Jak's otherwise flawed analysis . They lost 1.2m from the cash pile over the 2018, did they not (down from 3.7 to 2.5), and AIM companies always come back for more, no matter how hard they try to convince otherwise. Moreover, the CEO says that he wants to take more stuff in house, to facilitate ramp up of business: this costs money. If they return to the market, which I believe they will, it will be to get enough to build out the company's infrastructure to whatever size needed. And this can only be with the goodwill of Sipcam, their strategic partner/investor, who is also the main partner in the Sustainea re-encapsulation story. And I would also imagine their other investors would like to have share in that proposition, including us! Given the right prospectus, I don't see a problem. And that would also be the right moment for Lykele to deliver on his own promise to become a shareholder. So why do I remain bullish? Because I see this happening in 2019, followed by revenues building very significantly into 2020, and then impressively thereafter. As stated many times, my sightline is three years for a price of 50p-£1. Modest, I know...
brucie5
04/4/2019
15:30
Brucie, you forgot nit treatment, September this year for full retail sales UK and now licensed across EU which was conveyed as if it were a minor byline in this week's RNS, yet is fantastic news. Usa nit licence imminent, too.
paulpaolo
04/4/2019
14:59
Glyphoste / 5G = Extinction Symbol Concerns over glyphosate pass from human health to the soil hTTps://www.politico.eu/article/glyphosate-concerns-pass-from-human-health-to-soil/ Round3 hTTps://www.courthousenews.com/expert-flunks-epa-handling-of-roundup-approval/
supersonico
04/4/2019
11:43
I'll add to this by saying Eden's strapline is "The Natural Solution". Further, Eden states that its products are "based upon natural chemistries", so to me, it is imperative that Cedroz is not labelled as a pesticide in journalistic pieces or elsewhere.
investingisatrickygame
04/4/2019
10:43
I agree image and differentiation is key in this world of Eden , all these little things add up to the misunderstanding and total lack of understanding that is happening to Eden and has always happened.... grrrrrh
bjlk
04/4/2019
09:44
In Tours, neurobiology researchers have proven that glyphosate has an effect on mosquitoes hTTp://tinyurl.com/y32lc89q At the insect biology research institute in Tours, scientists have proved that glyphosate also affects the development of mosquitoes. This study, published in a prestigious international journal, has something to worry about. Reportage. The study by Fernando Mordi Guerrieri was published in 2018 in the prestigious journal "Journal of experimental biology". The neurobiologist has proved that the effects of the pesticide were not limited, as claimed by its manufacturers, to plants alone. Glyphosate affects the development of the mosquito. "When we raise a mosquito larva with a dose of glyphosate equivalent to what we can find residual in the field, we see that the mosquito larva no longer has its ability to learn." How to know if a mosquito is affected in its development? In his laboratory of the Irbi (Insect Biology Research Institute) of Tours, Fernado Guerrieri has reconstructed the natural development space of a mosquito larva. They evolve in the water with a mechanism that makes them shade. Like a leaf that would pass over them. "Mosquito larvae are aquatic animals that need to be hung on the surface of the water to breathe air, but when there is an object that moves above the surface, projecting a shadow, the larvae have the innate response of diving to avoid the potential danger, but the animal can not stay underwater for a long time, so it is important for the animal to learn to recognize the real dangers. 'non-dangerous object like a leaf projects its shadow several times on the surface, the larva learns that there is no danger and stops diving.This behavior is changed in the presence of glyphosate,' says the neurobiologist. What does this study tell us? This study reveals that contrary to what the manufacturers say since the 70s, this herbicide does not act only on plants. We already know that it has a neurotoxic effect on bees that, exposed to glyphosate do not find their way. It was also known that it affected the development of embryos of frogs. This study provides further evidence that the most used pesticide has an effect on animal development. "It proves the harmful effects of glyphosate on animals, on small animals, the effects are seen in a few days, on large animals like us, it will be seen in the longer term.We will have to make clinical studies and field observations in humans, to see what the consequences are for our health, not just to change the molecule for an equivalent molecule but to change the way we treat the environment to preserve biodiversity. " The neurobiologist calls on the government: "I think that the authorities and those who make the decisions should pay particular attention to scientific studies, we do them as a public service agent in the interest of citizens, rather than following recommendations made by corporations with special interests ". ……………………………………………………………………………………………. hTTps://www.youtube.com/watch?v=arx0T0qDqdo Cedric Bertrand Professeur, Université de Perpignan, UPVD, France. Cédric Bertrand specialist in natural substances Expert in phytochemistry and metabolomics, development of analytical methods for the analysis of complex matrices of natural origin. Support for the registration of biocontrol products, biopesticides and phytostimulants. Phytochemical study in the fields of cosmetics and food supplements. Development of an environmental impact study by metabolic profiling.
supersonico
04/4/2019
07:55
I think we are. I simply think it is important that the terminology is right. "Pesticides" have such a bad image, more recently heightened by Glyphosate. I believe biopesticides conjour up a totally different image and it is a selling point that Eden highlights. That being so, why not correct the article for the reading investment community! The image of Eden is important, as is its product differentiation.
investingisatrickygame
04/4/2019
05:41
Investing...No, you are nit picking! Pesticides is a very large umbrella term and can cover many aspects of crop protection, including fungicides! I don't ever see you moan when Mevalone is (and was in the article) referred to as a fungicide, when arguably its description would be biofungicide (or biopesticide). By putting bio in front (shortened from biological) it is now used to describe a wide range of pesticide and fungicide products that either contain living organisms, or they are derived from natural materials e.g. plant extracts and their essential oils. The following may be of interest (click plant extracts for particular relevance) - Biologicals are naturally occurring compounds or synthetically derived compounds that are structurally similar (and functionally identical) to their naturally occurring counterparts. Biologicals are divided into several different subcategories of products, including: hTTps://www.bpia.org/biochemical-products/ Btw, I am not sure we are on the same page.....at least not yet!
wan
03/4/2019
22:08
Wan, We are on the same page. Surely they should have called Cedroz a biopesticide, but not a pesticide. That is my point. Don't you agree?
investingisatrickygame
03/4/2019
20:38
One would imagine the BOD missed that.Probably they were not available to get the basic facts transcribed as a fact sheet.
chrischas
03/4/2019
20:03
Investing...Are you for real! Cedroz is a nematicide, it kills soil dwelling pests, nematodes....in other words, it is classified as a pesticide, in this case a biopesticide. So yes the biopesticide headline is appropriate, as the market for Cedroz is much larger than the 'current' market for Mevalone!
wan
03/4/2019
19:43
£2.8 in tenure include £1.2 in milestones and licensing fees. Do we have any sense of what fees are payable on envisaged events this year, aside of course from any deal on Sustainea? I can imagine mevalone sales/ revenues rising by at least 50%, still from a small base. Maybe some small cash dribbling in front Cedroz pre-sales. But to my mind Eden needs to clear at least £4m not including Sustaine. Then chocks away for 2020. I'm very much looking forward to see the Edison projection for 2021, as that's my timescale for this investment. With a share price between 50p and £1.
brucie5
03/4/2019
19:16
Wan, They make fundamental errors....again. The headline is about biopesticides, then they talk about Eden making biopesticides and then they create the cardinal sin and call Cedroz a ………;"Pesticide". It is so sloppy and potentially confusing to those reading about Eden for the first time. The article criticises pesticides and then apparently we are launching one!!!!!!!!!!!!
investingisatrickygame
03/4/2019
17:36
A good write up on Eden from Proactive Investors - http://tinyurl.com/Eden-Research-Poised I note that Shore Capital are still to update their financial expectations for Eden and will also introduce new forecasts for full-year 2021 (I wonder what they are waiting for!)
wan
03/4/2019
16:47
https://twitter.com/edenresearch More sloppy journalism in regards to Eden. We hardly get coverage and when we do it is frequently wrong. Why does the headline refer to biopesticides, state that Eden provides biopesticides and then talk about Eden launching a 'pesticide ' called Cedroz!
investingisatrickygame
03/4/2019
07:44
I'm persuaded that all modern police shows are a subtle way of selling Holidays, Kitchens and cars, but this goes too far. Family farm documentary was part of pesticide lobby's campaign to change how you think hTTps://www.nationalobserver.com/2019/03/27/news/family-farm-documentary-was-part-pesticide-lobbys-campaign-change-how-you-think The goal of the marketing efforts is to create more "shareworthy content" that would build public support for the use of pesticides and genetically modified organisms, according to the leaked presentation. It is coming to light at a time when the industry is under scrutiny over public health concerns that could prompt governments to impose tougher regulations that cut into profits.
supersonico
02/4/2019
16:30
I am for Real Jak that's your problem and why your on the back foot.
supersonico
02/4/2019
16:27
Re. 'pigs in a trough' - don't conflate the two issues. Overcompensation for underperformance of share price is not the same as an absence of promise.
brucie5
02/4/2019
16:25
JakNife 2 Apr '19 - 16:07 - 5949 of 5949 0 0 0 Brucie5, I don't understand what you're going on about. I've set out quite clearly my valuation of the company in plain and simple numbers. You're the one who seems incapable of expressing what's in your head into a number. --------------------------------------------------------------------- Where? Sorry, must have missed it. Not asking for the whole stable of would be runners, not even asking for the consumer and cap verticals, due to market this year; just the three crop sections which are either already on the market (Mevalone), in process of getting regulatory clearance (Cedroz) or being fairly clearly indicated (Sustainea). Where did you value these? Sorry, if I seem to have missed them. Show me.
brucie5
02/4/2019
16:07
Brucie5, "Jak, it's really not good enough to talk about my reliance of dreams, when you won't address the actual investment case." I don't understand what you're going on about. I've set out quite clearly my valuation of the company in plain and simple numbers. You're the one who seems incapable of expressing what's in your head into a number. supersonico, "Jak ..Always wrong all the time." Are you for real? I've been calling this as a sell for months on end whilst the share price has dropped and dropped and dropped. At the same time you've been calling it as a buy. Keep saying buy, one day you may be right. But it's good to see that we all agree that the directors paying themselves the grotesque excessive amounts that they've paid themselves for the last year is nothing short of pigs in the trough daylight robbery. regards, JakNife
jaknife
02/4/2019
15:43
Newsweek Gets Ad Money from Bayer, Prints Op-Eds That Help Bayer Newsweek failed to disclose the chemical industry connections of two opinion writers who argued today in an op-ed that glyphosate can’t be regulated. The commentary by Henry I. Miller and Stuart Smyth, both of whom have ties to Monsanto that were not disclosed in the piece, appeared soon after a federal jury handed cancer victim Edwin Hardeman an $80 million verdict against Monsanto (now Bayer), and said the company’s glyphosate-based Roundup herbicide was a “substantial factor” in causing Hardeman’s cancer. hTTps://usrtk.org/pesticides/newsweek-gets-ad-money-from-bayer-prints-op-eds-favorable-to-bayer/ I do question this Forbes article as well..while were on the subject of Paid opinion Pieces. Monsanto's Roundup Is Losing Ground, But It's Temporary hTTps://www.forbes.com/sites/yiannismouratidis/2019/04/01/monsantos-roundup-is-losing-ground-but-its-temporary/#699cd83e45bc
supersonico
02/4/2019
15:17
Emotional is right..he's still crying from the days Livingbridge and Sipcam made strategic investments when he was promising us all Bucket shops and Death Spirals. LOL Jak ..Always wrong all the time.
supersonico
Chat Pages: Latest  274  273  272  271  270  269  268  267  266  265  264  263  Older
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190826 07:01:50